NCT05633225

Brief Summary

Hypermobility Spectrum Disorder and hypermobile Ehlers-Danlos Syndrome (HSD/hEDS) is under-recognized and poorly understood and its management is therefore not clear. The goal of this study is to better understand pain and its impact on function in the daily activities of adolescents with Hypermobility Spectrum Disorder and/or hypermobile Ehlers-Danlos Syndrome. This study will explore the presence of the pain sensitivity status after physical exercise as well as movement behaviour in adolescents with HSD/hEDS compared to a healthy control group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2022

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 19, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

November 25, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 1, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2023

Completed
Last Updated

November 7, 2023

Status Verified

November 1, 2023

Enrollment Period

7 months

First QC Date

October 19, 2022

Last Update Submit

November 6, 2023

Conditions

Keywords

PainHypermobilityPhysical activityCentral sensitizationFatigueEhlers Danlos Syndrome

Outcome Measures

Primary Outcomes (2)

  • Pressure Pain thresholds, primary and secondary hyperalgesia

    A hand-held pressure algometer (Wagner Instruments, FPX 25) will be used to assess pressure pain thresholds (PPT). The 1 cm2 rubber tip of the algometer will be positioned at an angle of 90 degrees in relation to the body part evaluated and pressure will be applied at a rate of 1 kg/s. PPT measurements will be carried out on the lower back in the supine position, on the tibialis anterior in the prone position, on the trapezius and deltoid while sitting. The participants will be instructed to say "stop" as soon as the sensation of a pressure changes to an uncomfortable feeling. The pressure algometer will be removed immediately and the recorded value will be noted. This procedure will be repeated time three times at each test location (30 seconds between each measurement). Average value of the last two measurements is used as the baseline. The order of the PPT measurement points will be randomized for each group.

    Baseline, pre-intervention

  • Change of Pressure Pain thresholds, exercise-induced hyperalgesia

    Exercise-induced hyperalgesia will be measured by repeating the pressure pain thresholds (PPT) measures at the trapezius muscle and the tibialis anterior muscle (as described above) immediately after the performance of an submax exercise test on a bicycle ergometer The order of the PPT measurement points in the exercise-induced hyperalgesia measurements will be randomized for each group.

    Immediately after the intervention

Secondary Outcomes (14)

  • Numerical rating scale

    Baseline, pre-intervention and immediately after the intervention

  • Heart rate

    Immediately after the intervention

  • Borg Rating of Perceived Exertion Scale

    Immediately after the intervention

  • Medical examination

    Baseline, pre-intervention

  • Beighton scale

    Baseline, pre-intervention

  • +9 more secondary outcomes

Study Arms (2)

Patient-group

Ninety adolescents, 13-17 years of age Diagnosed with Hypermobility Spectrum Disorder or hypermobile Ehlers Danlos Syndrome.

Other: Submax exercise test on a bicycle ergometer

Control-group

Ninety adolescents, 13-17 years of age. Participants have to be pain free at time of investigation (NRS score \<3/10)

Other: Submax exercise test on a bicycle ergometer

Interventions

To achieve exertion and not exhaustion, cycling will be stopped at 75% of the expected maximum heart rate (maximum heart rate of 220 beats per minute minus age) as a target value. If the participant then indicated that they do not feel strained, the cycling will continue until the participant experienced an effort on Borg Rating of Perceived Exertion Scale scale of 15 (hard).

Control-groupPatient-group

Eligibility Criteria

Age13 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Adolecents diagnosed with HSD/hEDS, at Children's Primary Health Care Clinics in Gothenburg and Southern Bohuslän, and at Queen Silvia Children's Hospital and Skaraborgs hospital Skövde will be asked to participate. In addition, a control group of healthy pain free adolecents, matched for sex, age will be recruited from different schools in the region, throw hospital stuff and social media.

You may qualify if:

  • Able to read and understand Swedish
  • Diagnosed with HSD or hEDS

You may not qualify if:

  • Pregnancy and one year postpartum.
  • Other syndromes with hypermobility such as the Marfan syndrome, Osteogenesis Imperfecta or other types of EDS.
  • Co-morbidity with neurological disorders
  • Able to read and understand Swedish
  • Healthy
  • Pain free at time of investigation (Numerical Rating Scale score \<3/10).
  • Pregnancy and one year postpartum.
  • Past or present signs of rheumatic, neurologic, musculoskeletal, metabolic diseases.
  • Chronic pain.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Sahlgrenska University Hospital

Gothenburg, Region Västra Götaland, 416 85, Sweden

Location

Skaraborgs Hospital Skövde

Skövde, Region Västra Götaland, 54142, Sweden

Location

Related Publications (2)

  • Castori M, Tinkle B, Levy H, Grahame R, Malfait F, Hakim A. A framework for the classification of joint hypermobility and related conditions. Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):148-157. doi: 10.1002/ajmg.c.31539. Epub 2017 Feb 1.

    PMID: 28145606BACKGROUND
  • Schubert-Hjalmarsson E, Fridolfsson J, Arvidsson D, Borjesson M, Lundberg M. Exploring physical activity patterns in adolescents with hypermobility spectrum disorder or hypermobile Ehlers-Danlos Syndrome. Pediatr Rheumatol Online J. 2025 Jul 8;23(1):69. doi: 10.1186/s12969-025-01124-0.

Related Links

MeSH Terms

Conditions

Ehlers-Danlos syndrome type 3PainMotor ActivityFatigueEhlers-Danlos Syndrome

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehaviorHemostatic DisordersVascular DiseasesCardiovascular DiseasesHemorrhagic DisordersHematologic DiseasesHemic and Lymphatic DiseasesSkin AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSkin Diseases, GeneticGenetic Diseases, InbornCollagen DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesSkin Diseases

Study Officials

  • Mari Lundberg, Professor

    University of Gothenborg

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
RPT, Head of the occupational therapy and physiotherapy unit for children

Study Record Dates

First Submitted

October 19, 2022

First Posted

December 1, 2022

Study Start

November 25, 2022

Primary Completion

June 30, 2023

Study Completion

October 31, 2023

Last Updated

November 7, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

There is not a plan to make IPD available.

Locations